CND has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most recent Series A3 offering.

The firm raised a total of $13.5 million in its Series A equity financing round, which will go toward growing and advancing its neurodegenerative disease testing business.

Labour has been accused of covering up the planned deployment of US nukes to RAF Lakenheath - but CND are not having it ...

SCOTTSDALE, Ariz., May 1, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND) announced today that it has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most ...

Members of Parliament and senators gathered on May 2 at Kigali Genocide Memorial to honour the victims of the 1994 Genocide against the Tutsi, especially former staff of the CND (Conseil National de ...

Are you craving a nail product formula that’s ideal for detailed linework, smooth to apply and streak-free? Consider adding ...

Rabinder Singh QC, for CND, told three senior judges in London that UN Security Council Resolution 1441 of November 8 this year set out Saddam Hussein's disarmament obligations, but did not ...

Police have given an update after seven people were arrested outside a Suffolk airbase, following an anti-nuclear weapons ...

Global Oil & Gas ( ($AU:CND) ) just unveiled an announcement. Condor Energy Limited has announced a significant increase in its resource estimates ...

M Shed will host a rare exhibition showcasing Bristol’s powerful history of anti-nuclear protests and activism this weekend ...

The blockade will take place from noon on the final day of the Lakenheath Alliance for Peace camp, which has had a continuous presence outside the US air force base in Suffolk since April 14. CND ...